國家衛生研究院 NHRI:Item 3990099045/4699
English  |  正體中文  |  简体中文  |  全文筆數/總筆數 : 12145/12927 (94%)
造訪人次 : 855457      線上人數 : 1127
RC Version 6.0 © Powered By DSPACE, MIT. Enhanced by NTU Library IR team.
搜尋範圍 查詢小技巧：
  • 您可在西文檢索詞彙前後加上"雙引號"，以獲取較精準的檢索結果
  • 若欲以作者姓名搜尋，建議至進階搜尋限定作者欄位，可獲得較完整資料
    •  進階搜尋
    主頁 ‧ 登入 ‧ 上傳 ‧ 說明 ‧ 關於NHRI ‧ 管理 到手機版


    請使用永久網址來引用或連結此文件: http://ir.nhri.org.tw/handle/3990099045/4699


    題名: Treating primary dysmenorrhea with a Chinese herb formula, four-agents-decoction
    其他題名: O-232: Treating primary dysmenorrhea with a Chinese herb formula, four-agents-decoction
    作者: Liu, J;Liang, L;Lin, K;Liu, Y;Tsai, T;Wang, L
    貢獻者: Division of Clinical Research
    摘要: OBJECTIVE: Four-Agents-Decoction (Si Wu Tang) is a traditional Chi-nese herbal formula widely used for relieving menstrual discomforts formany years, especially in Chinese and Asian populations. We assessed itseffectiveness in treating primary dysmenorrhea by a rigorous clinical trial.DESIGN: a Randomized Placebo-controlled Clinical Trial.MATERIALS AND METHODS: Randomized, double-blind, placebo-controlled clinical trial was conducted between 2001 and 2004 enrolling 78primary dysmenorrheic women after screening 326 women from colleges inthe Taipei metropolitan area of Taiwan. Women had organic lesions wereexcluded, determined by non-invasive pelvic ultrasonography and normalserum CA-125 level. Participants were followed with two to four cycles foran initial washout interval, one to two baseline cycles, three to four treatmentcycles and three follow-up cycles. Menstrual pain intensity wasmeasured by visual analog scale of 0-10 cm on on-line diary.RESULTS: The menstrual pain intensity did not differ by capsulatedFour-Agents-Decoction (FAD) and placebo after 3-cycle treatment. In orderto meet our schedule for group post-treatment examination, 42 women withshorter menstrual cycle had 4 cycles of treatment. To our surprise, theoverall pain (averaged daily pain intensity) was lower in the 20 women withFAD (2.52 2.12) than in the 22 women with placebo (3.90 2.44; p .064).Furthermore, regardless of treatment length, the pain difference persisted tothe first follow-up cycle of post-treatment phase, when all 38 women withFAD (2.63 1.94) were compared to all 38 women with placebo(3.76 2.47; p .029). This significant difference is also attributed to thewomen with 4 treatment cycles (2.18 1.66 for the 20 women with FAD vs.3.93 2.72 for the 22 women with placebo; p .017). The pain intensity ofthe FAD group increased at the second and third follow-up cycles, but stilllower than that at baseline.CONCLUSION: With our dosage regimen and treatment of four cycles,capsulated FAD improves primary dysmenorrhea. Another trial with longertreatment period and larger sample size is needed to study its curing effectand to set an optimal dose, and the validity of the regimen in differentgeographical areas and races. A trial evaluating the effects of the quality ofFAD with the capsulated FAD manufactured from different batches of theherbs should also be conducted.
    日期: 2006-09
    關聯: Fertility and Sterility. 2006 Sep;86(Suppl. 2):S99-S100.
    Link to: http://dx.doi.org/10.1016/j.fertnstert.2006.07.265
    JIF/Ranking 2023: http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=NHRI&SrcApp=NHRI_IR&KeyISSN=0015-0282&DestApp=IC2JCR
    Cited Times(WOS): https://www.webofscience.com/wos/woscc/full-record/WOS:000241038500232
    顯示於類別:[梁蘭蘭(1998-2006)] 會議論文/會議摘要

    文件中的檔案:

    檔案 描述 大小格式瀏覽次數
    ISI000241038500232.pdf92KbAdobe PDF622檢視/開啟


    在NHRI中所有的資料項目都受到原著作權保護.

    TAIR相關文章

    DSpace Software Copyright © 2002-2004  MIT &  Hewlett-Packard  /   Enhanced by   NTU Library IR team Copyright ©   - 回饋